Healthcare

VistaGen Therapeutics (NASDAQ : VTGN) Analysis

 Vistagen (Nasdaq: VTGN) is a San Francisco-based biopharmaceutical company pioneering neuroscience. Its treatments deliver ground-breaking therapies for individuals affected by psychiatric and neurological disorders. Recently,...

NurExone Unlocks Several Milestones Since March 2024 (TSXV: NRX, FSE: J90, NRX.V)

● Leading the charge in exosome-based medicine, NurExone pioneers ExoTherapy, utilizing tiny cell-secreted particles to deliver treatments like ExoPTEN, focusing on spinal cord injury recovery — a...

The Rise of NurExone Biologic Inc. in Biopharma (TSXV: NRX, FSE: J90, NRX.V)

NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone") is a pioneering biopharmaceutical company developing regenerative medicine therapies. As you can see...

NuGen Medical Devices Inc.(TSXV: NGMD) : Leading developer of needle-free devices

NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) is a leading developer of needle-free devices to administer therapeutics subcutaneously. No more needle phobia. NGMD’s...

NurExone gains traction in Europe with Orphan drug designation awarded by regulator (TSXV: NRX) (FSE: J90) (NRX.V)

NurExone Biologic Inc. is a TSXV-listed pharmaceutical company that is developing a platform for biologically-guided ExoTherapy to be delivered, non-invasively, to patients who suffer...

Popular

Subscribe

spot_imgspot_img